# The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery

> **NCT02188576** · PHASE4 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 66 (actual)

## Conditions studied

- Craniosynostosis

## Interventions

- **DRUG:** high dose TXA
- **DRUG:** Low dose TXA

## Key facts

- **NCT ID:** NCT02188576
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2020-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02188576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02188576, "The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02188576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*